Organovo Holdings Inc (ONVO)
0.9898
-0.01
(-1.02%)
USD |
NASDAQ |
Apr 25, 16:00
0.9836
-0.01
(-0.63%)
After-Hours: 20:00
Organovo Holdings Cash from Financing (TTM): 1.173M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 1.173M |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | -0.001M |
June 30, 2022 | -0.046M |
March 31, 2022 | 0.205M |
December 31, 2021 | 20.96M |
September 30, 2021 | 24.03M |
June 30, 2021 | 24.09M |
March 31, 2021 | 23.84M |
December 31, 2020 | 3.082M |
September 30, 2020 | 0.01M |
June 30, 2020 | -0.01M |
March 31, 2020 | 4.935M |
December 31, 2019 | 11.26M |
September 30, 2019 | 13.11M |
June 30, 2019 | 15.19M |
March 31, 2019 | 13.15M |
December 31, 2018 | 8.948M |
September 30, 2018 | 10.19M |
June 30, 2018 | 10.06M |
March 31, 2018 | 10.11M |
December 31, 2017 | 8.259M |
Date | Value |
---|---|
September 30, 2017 | 31.16M |
June 30, 2017 | 34.20M |
March 31, 2017 | 31.25M |
December 31, 2016 | 30.98M |
September 30, 2016 | 5.239M |
June 30, 2016 | 0.164M |
March 31, 2016 | 43.45M |
December 31, 2015 | 49.83M |
September 30, 2015 | 49.83M |
June 30, 2015 | 66.05M |
March 31, 2015 | 23.09M |
December 31, 2014 | 20.59M |
September 30, 2014 | 20.73M |
June 30, 2014 | 48.70M |
March 31, 2014 | 48.37M |
December 31, 2013 | 53.72M |
September 30, 2013 | 55.01M |
June 30, 2013 | 11.00M |
December 31, 2012 | 24.62M |
September 30, 2012 | 15.40M |
June 30, 2012 | 13.72M |
March 31, 2012 | 13.62M |
December 31, 2011 | 0.0095M |
September 30, 2011 | 0.00 |
June 30, 2011 | 0.0001M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.046M
Minimum
Jun 2022
24.09M
Maximum
Jun 2021
7.464M
Average
1.173M
Median
Dec 2023
Cash from Financing (TTM) Benchmarks
Marinus Pharmaceuticals Inc | 26.63M |
Cartesian Therapeutics Inc | -13.14M |
Adial Pharmaceuticals Inc | 4.132M |
Longeveron Inc | 5.262M |
Viracta Therapeutics Inc | 0.438M |